Loading…
Based on limited metadata from this FDA Warning Letter, Niche Pharmaceuticals, Inc. received a warning from the FDA on July 19, 2018, regarding compliance issues with a product classified as "Other" (not a standard drug, device, or biologic category). Without access to the full warning letter text or specific subject line details, the precise nature of the violations cannot be determined from the available information. The issuing office is also not specified in the metadata, limiting clarity on which FDA division or center initiated the enforcement action.